The company has already raised about $40 million to date.
{iframe}https://www.bizjournals.com/washington/news/2019/02/26/gaithersburg-biotech-raising-second-round-of.html{/iframe}
NexImmune raising $10M for AML drug trials – Washington Business Journal
The company has already raised about $40 million to date.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.